# Tempest Therapeutics, Inc. (TPST)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TPST/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -27.70M | $ 0 | $ 7.85M | $ 822.0K |
| 2025 | $ 0 | $ -26.89M | $ -27.46M | $ 8.14M | $ 6.67M |
| 2024 | $ 0 | $ -43.98M | $ -35.17M | $ 15.37M | $ 19.13M |
| 2023 | $ 0 | $ -31.89M | $ -29.76M | $ 20.66M | $ 26.77M |
| 2022 | $ 0 | $ -39.89M | $ -35.34M | $ 22.11M | $ 18.11M |
| 2021 | $ 0 | $ -33.64M | $ -31.01M | $ 18.54M | $ 36.12M |
| 2020 | $ 0 | $ -24.47M | $ -24.29M | $ 2.44M | $ -68.79M |
| 2019 | $ 0 | $ -57.53M | $ -53.72M | $ 4.52M | $ 58.55M |
| 2018 | $ 4.96M | $ -35.91M | $ -30.88M | $ 572.0K | $ 70.95M |
| 2017 | $ 396.1K | $ -68.67M | $ -61.58M | $ 0 | $ 64.30M |
| 2016 | $ 898.4K | $ -113.18M | $ -88.49M | $ 0 | $ 108.22M |
| 2015 | $ 388.9K | $ -102.80M | $ -77.95M | $ 0 | $ 126.85M |
| 2014 | $ 13.76M | $ -69.97M | $ -47.18M | $ 0 | $ 55.33M |
| 2013 | $ 0 | $ -41.31M | $ -26.76M | $ 0 | $ 41.70M |
| 2012 | $ 0 | $ -9.17M | N/A | $ 0 | $ 34.41M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 9.55 |
| Liabilities / Eq | 12.08 |
| Current Ratio | 0.74 |

## Other views

- [Metrics](https://sponda.capital/en/TPST.md)
- [Charts](https://sponda.capital/en/TPST/charts.md)
- [Compare](https://sponda.capital/en/TPST/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.